LAUSR

ABSTRACT Introduction: Management of ocular tuberculosis (OTB) poses a significant challenge due to heterogenous clinical presentations and persistent gaps in detection and treatment. The role of antitubercular therapy (ATT) still remains controversial, without international agreement regarding initiation and duration of ATT and concurrent use of systemic corticosteroids. Areas covered: This review serves the purpose of quick reference for ophthalmologists, providing guidance regarding the treatment of OTB in collaboration with pulmonologists and infectious disease specialists. Expert opinion: A large-scale international study is required to reach meaningful conclusions that will define the relevance of phenotypes, results of tests, and response to therapy. Only by pooling together resources, knowledge, experience, and data, can the understanding of OTB be improved.